logo

Akebia Therapeutics Inc. Inc. (AKBA) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 31.45%. However, over the last six months, the performance has been weaker by 45.54%. The price of AKBA increased 3.16% over the last 30 days. And in the last five days, it has fallen by -24.88%.

Akebia Therapeutics Inc. experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $2.48 on 03/28/24, while the lowest price for the same period was registered at $0.49 on 04/05/23.

52-week price history of AKBA Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Akebia Therapeutics Inc.’s current trading price is -34.27% away from its 52-week high, while its distance from the 52-week low is 232.59%. The stock’s price range during this period has varied between$0.49 and $2.48. The Akebia Therapeutics Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 14.01 million for the day, a figure considerably higher than their average daily volume of 4.16 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 27.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 341.27M and boasts a workforce of 167 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4016, with a change in price of +0.6851. Similarly, Akebia Therapeutics Inc. recorded 3,205,607 in trading volume during the last 100 days, posting a change of +72.51%.

AKBA Stock Stochastic Average

As of today, Akebia Therapeutics Inc.’s raw stochastic average for the last 50 days stands at 28.57%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 25.44%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 37.13% and 54.21%, respectively.